Highlights and Quick Summary
- Gross Profit Growth for the quarter ending June 30, 2023 was 0.59 (a 2.52% increase compared to previous quarter)
- Year-over-year quarterly Gross Profit Growth decreased by -211.88%
- Annual Gross Profit Growth for 2022 was -2.07 (a 274.24% increase from previous year)
- Annual Gross Profit Growth for 2021 was -0.55 (a -64.98% decrease from previous year)
- Annual Gross Profit Growth for 2020 was -1.58 (a -84.62% decrease from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Gross Profit Growth of Dyne Therapeutics, Inc.
Most recent Gross Profit Growthof DYN including historical data for past 10 years.Interactive Chart of Gross Profit Growth of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Gross Profit Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 0.59 | 0.58 | – | – | – |
| 2022 | -0.8 | -0.53 | -5.81 | -5.35 | -2.07 |
| 2021 | – | -0.57 | -0.3 | -1.41 | -0.55 |
| 2020 | – | – | 0.36 | 0.23 | -1.58 |
| 2019 | – | – | – | 0.59 | -10.29 |
| 2018 | – | – | – | – | 0.91 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology